ID: ALA3417041

Max Phase: Preclinical

Molecular Formula: C176H271N55O44S6

Molecular Weight: 4053.85

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O

Standard InChI:  InChI=1S/C176H271N55O44S6/c1-14-92(12)139-172(275)231-62-34-49-130(231)168(271)219-121(75-136(241)242)157(260)216-118(72-131(181)234)154(257)217-120(74-135(239)240)156(259)202-105(43-25-28-56-179)149(252)222-126-83-279-277-81-124(161(264)206-103(41-23-26-54-177)145(248)213-115(68-96-50-52-99(233)53-51-96)159(262)228-137(90(8)9)169(272)208-110(140(183)243)66-94-35-17-15-18-36-94)224-152(255)116(69-97-76-197-102-40-22-21-39-100(97)102)214-147(250)107(45-30-58-194-174(186)187)204-153(256)117(70-98-77-192-86-199-98)215-150(253)112(64-88(4)5)211-146(249)108(46-31-59-195-175(188)189)205-160(263)122(79-232)220-164(267)127-84-280-281-85-128(166(269)229-139)223-148(251)104(42-24-27-55-178)201-144(247)106(44-29-57-193-173(184)185)203-151(254)114(67-95-37-19-16-20-38-95)209-141(244)93(13)200-133(236)78-198-143(246)111(63-87(2)3)210-163(266)123(221-142(245)101(180)71-134(237)238)80-276-278-82-125(225-165(126)268)162(265)207-109(47-32-60-196-176(190)191)171(274)230-61-33-48-129(230)167(270)218-119(73-132(182)235)155(258)212-113(65-89(6)7)158(261)227-138(91(10)11)170(273)226-127/h15-22,35-40,50-53,76-77,86-93,101,103-130,137-139,197,232-233H,14,23-34,41-49,54-75,78-85,177-180H2,1-13H3,(H2,181,234)(H2,182,235)(H2,183,243)(H,192,199)(H,198,246)(H,200,236)(H,201,247)(H,202,259)(H,203,254)(H,204,256)(H,205,263)(H,206,264)(H,207,265)(H,208,272)(H,209,244)(H,210,266)(H,211,249)(H,212,258)(H,213,248)(H,214,250)(H,215,253)(H,216,260)(H,217,257)(H,218,270)(H,219,271)(H,220,267)(H,221,245)(H,222,252)(H,223,251)(H,224,255)(H,225,268)(H,226,273)(H,227,261)(H,228,262)(H,229,269)(H,237,238)(H,239,240)(H,241,242)(H4,184,185,193)(H4,186,187,194)(H4,188,189,195)(H4,190,191,196)/t92-,93-,101-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,137-,138-,139-/m0/s1

Standard InChI Key:  RTOOFVOZLOJQBN-FCHOXOAJSA-N

Associated Targets(Human)

Sodium channel protein type IX alpha subunit 8393 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Sodium channel protein type V alpha subunit 3462 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Sodium channel protein type IV alpha subunit 583 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 4053.85Molecular Weight (Monoisotopic): 4050.8983AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Murray JK, Ligutti J, Liu D, Zou A, Poppe L, Li H, Andrews KL, Moyer BD, McDonough SI, Favreau P, Stöcklin R, Miranda LP..  (2015)  Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(V)1.7 sodium channel.,  58  (5): [PMID:25658507] [10.1021/jm501765v]

Source